PDB4 MODELING HEALTH AND ECONOMIC OUTCOMES ASSOCIATED WITH EXENATIDE ONCE-WEEKLY VERSUS INSULIN AND PIOGLITAZONE TREATMENT FOR TYPE-2 DIABETES

Authors :: Amy Blickensderfer
Matthew Wintle
Barbara Peskin
Julia A Gaebler
Peter Alperin
Jenny Han
David G. Maggs
D Bruhn
Richard Pencek
Byron J. Hoogwerf
G. Soto-Campos
Source :: Value in Health. 14:A91
Publication Year :: 2011
Publisher :: Elsevier BV, 2011.

Subjects :: medicine.medical_specialty
business.industry
Health Policy
Insulin
medicine.medical_treatment
Public Health, Environmental and Occupational Health
Type 2 diabetes
medicine.disease
Internal medicine
Exenatide once weekly
Medicine
business
Pioglitazone
medicine.drug

Full Text Access

Tools